期刊文献+

STAT6 mRNA与NF-κB在实验性结肠炎大鼠中的表达 被引量:3

Expression of STAT6 mRNA and NF-κB in rats with experimental ulcerative colitis
暂未订购
导出
摘要 目的研究信号转导和转录激活因子6(STAT6)与核因子(NF)-κB在实验性结肠炎大鼠中的表达。方法 18只SD雄性大鼠随机分为3组:正常对照组、模型组、美沙拉嗪组,每组6只。模型组和美沙拉嗪组大鼠均采用三硝基苯磺酸(TNBS)造模。模型组不设干预,正常饮食;美沙拉嗪组给予美沙拉嗪混悬液灌胃;治疗15d后观察大鼠的结肠病理组织学改变,用RT-PCR法检测大鼠结肠组织STAT6mRNA的表达,并用Western Blot法检测大鼠脾淋巴细胞NF-κBp65的表达。结果 STAT6 mRNA在溃疡性结肠炎组织中的表达明显高于正常结肠组织(P<0.01);大鼠脾淋巴细胞NF-κBp65蛋白在模型组的表达也明显高于正常组(P<0.01);与模型组相比,美沙拉嗪组STAT6 mRNA和NF-κBp65的表达明显下降(P<0.01)。结论 STAT6 mRNA和NF-κB p65在实验性结肠炎大鼠中呈现高表达。美沙拉嗪可能是通过STAT6和NF-κB双信号途径下调炎症,从而发挥治疗作用。 Objective To evaluate the expression of signal transducer and activator of transcription 6 (STAT6) and nuclear factor-κB (NF-κB) in rats with experimental ulcerative colitis (UC). Methods 18 male rats were randomly assigned to the following groups (n = 6): control group, model group, mesalazine group. The rats were induced by trinitrobenzene sulfonic acid (TNBS) in model group and mesalazJne group. The rats in mesalazine group were given mesalazine through intragastrie administration for 15 days. Colonic histopalhologic changes were observed. The expression of STAT6 mRNA of UC tissue was detected by RT PCR, and the protein expression of NF-κB p65 was analyzed by western blot method. Results Compared with the control group, there was elevated expression of STAT6 mRNA and NF-κB p65(P〈0.01 ) in rats with experimental UC. After UC model treated with mesalazine, the level of STAT6 mRNA and NF-κB p65 was significantly decreased (P〈0. 01) in mesalazine group. Conelusions High expression of STAT6 mRNA and NF-κB p65 in rats with experimental ulcerative colitis, and regulating the expression of STAT6 and NF-κB double signal transduction pathway may be the anti-inflammatory mechanism of mesalazine.
出处 《国际消化病杂志》 CAS 2010年第5期311-313,共3页 International Journal of Digestive Diseases
基金 国家自然科学基金项目(30772878)
关键词 结肠炎 美沙拉嗪 信号转导和转录激活因子6 核因子-ΚB P65 Colitis Mesalazine Signal transducer and activator of transcription 6 Nuclear factor-κB p65
  • 相关文献

参考文献5

二级参考文献80

  • 1[30]Fernandez V,Tapia G,Varela P,Castillo I,Mora C,Moya F,Orellana M,Videla LA.Redox up-regulated expression of rat liver manganese superoxide dismutase and Bcl-2 by thyroid hormone is associated with inhibitor of kappaB-alpha phosphorylation and nuclear factor-kappaB activation.J Endocrinol 2005; 186:539-547
  • 2[31]Campbell JS,Prichard L,Schaper F,Schmitz J,Stephenson-Famy A,Rosenfeld ME,Argast GM,Heinrich PC,Fausto N.Expression of suppressors of cytokine signaling during liver regeneration.J Clin Invest 2001; 107:1285-1292
  • 3[32]Kaido T,Oe H,Imamura M.Interleukin-6 augments hepatocyte growth factor-induced liver regeneration;involvement of STAT3 activation.Hepatogastroenterology 2004;51:1667-1670
  • 4[33]Albrecht JH,Hansen LK.Cyclin D1 promotes mitogenindependent cell cycle progression in hepatocytes.Cell Growth Differ 1999; 10:397-404
  • 5[34]Weinstein M,Monga SP,Liu Y,Brodie SG,Tang Y,Li C,Mishra L,Deng CX.Smad proteins and hepatocyte growth factor control parallel regulatory pathways that converge on beta1-integrin to promote normal liver development.Mol Cell Biol 2001; 21:5122-5131
  • 6[35]Armendariz-Borunda J,Katai H,Jones CM,Seyer JM,Kang AH,Raghow R.Transforming growth factor beta gene expression is transiently enhanced at a critical stage during liver regeneration after CCl4 treatment.Lab Invest 1993; 69:283-294
  • 7[36]Armbrust T,Batusic D,Xia L,Ramadori G.Early gene expression of hepatocyte growth factor in mononuclear phagocytes of rat liver after administration of carbon tetrachloride.Liver 2002; 22:486-494
  • 8[37]Rozga J.Hepatocyte proliferation in health and in liver failure.Med Sci Monit 2002; 8:RA32-RA38
  • 9[38]Marino MW,Dunn A,Grail D,Inglese M,Noguchi Y,Richards E,Jungbluth A,Wada H,Moore M,Williamson B,Basu S,Old LJ.Characterization oftumor necrosis factordeficient mice.Proc Natl Acad Sci USA 1997; 94:8093-8098
  • 10[39]Yamada Y,Kirillova I,Peschon JJ,Fausto N.Initiation of liver growth by tumor necrosis factor:deficient liver regeneration in mice lacking type Ⅰ tumor necrosis factor receptor.Proc Natl Acad Sci USA 1997; 94:1441-1446

共引文献63

同被引文献36

  • 1庞艳华,郑长青,宁斌,胡刚正,张文杰.信号转导和转录激活因子6在溃疡性结肠炎中的表达[J].世界华人消化杂志,2004,12(10):2484-2486. 被引量:7
  • 2梁雄均,马泽粦,曾雅静.白介素4和17在溃疡性结肠炎发生发展中的作用[J].右江医学,2005,33(1):6-8. 被引量:13
  • 3庞艳华,郑长青,王轶淳,李晓东,李丰.IL-4和IL-13在溃疡性结肠炎中的表达[J].胃肠病学和肝病学杂志,2005,14(4):410-412. 被引量:24
  • 4庞艳华,郝建宇,张文杰,郑长青.溃疡性结肠炎中信号转导和转录活化因子6的活化表达及作用[J].中华消化杂志,2007,27(10):679-681. 被引量:1
  • 5Fiocchi C. Inflammatory bowel disease: etiology and Pathogenesis [ J ]. Gastroenter - ology, 1998,115 ( 1 ) : 182 - 205.
  • 6Oettgen HC. Regulation of the IgE isotype switch: new insights on eytokine signals and the functions of e germline transcripts [ J]. Curr OPin Immuno1,2000 ,12 :618 - 623.
  • 7Yu CR, Mahdi RM, Ebong S, et al. Cell proliferation and STAT6 pathways are negatively regulated in T cells by STAT1 and sup- pressors of cytokin e signaling [ J ]. J Inamunol, 2004,173 ( 2 ) : 737 - 746.
  • 8Dickensheets HL, Vnkataraman C, Schindler U, et al. Interfer- ons inhibit activation of STAT6 by interleukin 4 in human mono- cytes by inducing SOCS - 1 gene expression[ J]. Proc Natl Acad Sci USA, 1999,96 ( 19 ) : 10800 - 10805.
  • 9YU C R,MAHDI R M,EBONG S,et al.Cell proliferation and STAT6 pathways are negatively regulated in T cells by STAT1 and suppressors of cytokin e signaling[J].Journal of Immunology,2004,173(2):737-746.
  • 10DICKENSHEETS H L,VNKATARAMAN C,SCHINDLER U,et al.Interferons inhibit activation of STAT6 by interleukin 4 in human monocytes by inducing SOCS-1 gene expression[J].Proceedings of the National Academy of Sciences of the United States of America,1999,96(19):10800-10805.

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部